Internal Medicine, Nephrology · Paramus, NJ
NPI
1033190103
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1 Kalisa Way, Suite 210
Paramus, NJ, 07652
Phone (201) 447-0013
Groups this clinician bills Medicare through
Medicare paid, 2024
$388K
6,376 services
Medicare patients, 2024
1,130
Average age 77
Drug cost, 2024
$915K
3,413 prescriptions
Company payments, 2025
$56.07
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard Weizman was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 2,568 times for 18 patients. In total Howard Weizman billed 6,376 services in 23 codes, and Medicare paid $388K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,568 | 18 | $6.31 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 785 | 363 | $71.12 | $56K |
| 99213 Office E&M - Established | Office | 718 | 465 | $71.37 | $51K |
| 90960 ESRD Related Services (not dialysis) | Office | 400 | 68 | $317.54 | $127K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 390 | 129 | $57.73 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 315 | 295 | $14.79 | $4,659 |
| 99222 Hospital E&M - Initial | Facility | 244 | 226 | $117.82 | $29K |
| 99214 Office E&M - Established | Office | 228 | 212 | $116.85 | $27K |
| 99233 Hospital E&M - Subsequent | Facility | 199 | 110 | $106.75 | $21K |
| 90935 Hemodialysis | Facility | 164 | 94 | $63.87 | $10K |
| 96372 Injection Administration | Office | 138 | 18 | $13.13 | $1,811 |
| 99204 Office E&M - New | Office | 73 | 73 | $138.60 | $10K |
| 90970 ESRD Related Services (not dialysis) | Office | 58 | 18 | $8.57 | $497 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 22 | 16 | $44.50 | $979 |
| 90961 ESRD Related Services (not dialysis) | Office | 20 | 14 | $266.73 | $5,335 |
By year: 2022 $433K for 4,917 services; 2023 $564K for 6,663 services; 2024 $388K for 6,376 services.
Medicare prescription drug claims, 2024
In 2024, the drug Howard Weizman prescribed most often to Medicare patients was Amlodipine Besylate, with 323 prescriptions and refills. In total Howard Weizman wrote 3,413 Medicare prescriptions that cost $915K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 323 | 904 | 95 | $2,477 |
| Losartan Potassium Generic | 151 | 429 | 53 | $1,813 |
| Atorvastatin Calcium Generic | 137 | 399 | 48 | $1,300 |
| Metoprolol Succinate Generic | 108 | 317 | 36 | $1,743 |
| Allopurinol Generic | 106 | 297 | 34 | $1,109 |
| Doxazosin Mesylate Generic | 105 | 295 | 35 | $2,978 |
| Hydrochlorothiazide Generic | 102 | 299 | 32 | $504 |
| Sevelamer Carbonate Generic | 87 | 190 | 27 | $29K |
| Hydralazine Hcl Generic | 84 | 235 | 29 | $2,116 |
| Furosemide Generic | 81 | 171 | 30 | $274 |
| Nifedipine Er Nifedipine | 67 | 181 | 25 | $2,925 |
| Clonidine Hcl Generic | 61 | 165 | 20 | $1,040 |
| Rosuvastatin Calcium Generic | 59 | 161 | 19 | $703 |
| Lisinopril Generic | 59 | 165 | 24 | $302 |
| Torsemide Generic | 57 | 123 | 17 | $1,353 |
Brand drugs: 307 claims; generic drugs: 3,090 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard Weizman $56.07 ($56.07 in general payments such as food, travel and fees) from 1 company. The largest payer was Fresenius USA Marketing, Inc. with $56.07.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 3 | $56.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.